Published in TB and Outbreaks Week, May 18th, 1998
The authors concluded that "further investigations are needed to examine this syndrome and its possible relation to this vaccine."
Despite this note of caution, public confidence in the MMR vaccine diminished.
Now researchers in Finland have presented their data, as a Research Letter in the May 2, 1998, issue of The Lancet, which show no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.